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The Risks of Stone Diagnosis and Stone Removal
Procedure After Different Bariatric Surgeries
Steven M. Monda, MD, MSCI,1,2 Joel M. Vetter, MS,1 Margaret A. Olsen, PhD,3,4 Matthew R. Keller, MS,3
J. Christopher Eagon, MD,5 Michael S. Chevinsky, MD,1 Vasian Markollari, BS,3
Ramakrishna Venkatesh, MD,1 and Alana C. Desai, MD1

Abstract

Introduction: Nephrolithiasis is common after malabsorptive bariatric surgery; however, the comparative risk
of stone formation after different bariatric surgeries remains unclear. We seek to compare the risk of stone
diagnosis and stone procedure after gastric banding (GB), sleeve gastrectomy (SG), short-limb Roux-en-Y
(SLRY), long-limb Roux-en-Y (LLRY), and biliopancreatic diversion with duodenal switch (BPDDS).
Patients and Methods: Using an administrative database, we retrospectively identified 116,304 patients in the
United States, who received bariatric surgery between 2007 and 2014, did not have a known kidney stone
diagnosis before surgery, and were enrolled in the database for at least 1 year before and after their bariatric
surgery. We used diagnosis and procedural codes to identify comorbidities and events of interest. Our primary
analysis was performed with extended Cox proportional hazards models using time to stone diagnosis and time
to stone procedure as outcomes.
Results: The adjusted hazard ratio of new stone diagnosis from 1 to 36 months, compared to GB, was 4.54 for
BPDDS (95% confidence interval [CI] 3.66–5.62), 2.12 for LLRY (95% CI 1.74–2.58), 2.15 for SLRY (95% CI
2.02–2.29), and 1.35 for SG (95% CI 1.25–1.46). Similar results were observed for risk of stone diagnosis from
36 to 60 months, and for risk of stone removal procedure. Male sex was associated with an overall 1.63-fold
increased risk of new stone diagnosis (95% CI 1.55–1.72).
Conclusions: BPDDS was associated with a greater risk of stone diagnosis and stone procedures than SLRY
and LLRY, which were associated with a greater risk than restrictive procedures. Nephrolithiasis is more
common after more malabsorptive bariatric surgeries, with a much greater risk observed after BPDDS and for
male patients.
Keywords: bariatric surgery, endourology, epidemiology, kidney stones, nephrolithiasis, urolithiasis

Introduction

T

he incidence of obesity and its associated morbidity
continues to rise.1 A variety of different bariatric surgeries are currently used to induce weight loss in this population. These surgeries achieve weight loss and correct associated
metabolic comorbidities, such as diabetes mellitus and hypertension, through a combination of complex mechanisms that
include malabsorption and restriction. They are also associated
with a variety of adverse sequelae, including the well-known
and long-term complication of nephrolithiasis.2 Malabsorptive

bariatric surgery increases urinary oxalate levels and predisposes patients to kidney stone formation.3 However, bariatric
surgeries that are primarily restrictive, that is, gastric banding
(GB), have been largely shown to be free from this association.4,5 Nevertheless, bariatric surgery exists on a spectrum of
malabsorption and restriction, and the comparative risks of
nephrolithiasis across the spectrum of modern bariatric surgery
remain unclear.
Sleeve gastrectomy (SG) and GB are restrictive bariatric
surgeries that constrain the gastric lumen, either through resection or through adjustable banding. Alternatively, biliopancreatic
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diversion with duodenal switch (BPDDS) is the most malabsorptive modern bariatric surgery whereby much of the
small bowel is bypassed leaving a long biliopancreatic limb
and a short residual common channel. Intermediary between
BPDDS and restrictive surgery is the Roux-en-Y gastric bypass
wherein the length of the ‘‘Roux’’ limb can be lengthened to
yield a shorter common channel and a more malabsorptive
procedure, that is, the long-limb Roux-en-Y (LLRY) is more
malabsorptive than short-limb Roux-en-Y (SLRY).
There are limited data assessing the rates of nephrolithiasis
associated with the distinct types of bariatric surgeries. Herein,
we seek to evaluate the association between the different types
of bariatric surgeries and subsequent kidney stone diagnoses
and stone removal procedures. In doing so, we attempt to test
whether the risk of kidney stones is greater in procedures that
are more malabsorptive. We hypothesize that GB and SG, as
restrictive procedures, will have similarly low rates of nephrolithiasis, and that SLRY, LLRY, and BPDDS will have
increasingly higher rates of nephrolithiasis. By clarifying the
varying rates of diagnosed and treated kidney stones among
the different bariatric procedures, we will allow bariatric
surgeons and other providers caring for this population to
better counsel patients on a prominent long-term complication of these surgeries.
Patients and Methods
Patient selection and variable identification

This is a retrospective administrative data analysis using
the Truven Health MarketScan Commercial Database that
received Institutional Review Board Waiver at our institution. This database includes longitudinal inpatient and outpatient medical and prescription drug claims from numerous
employer-sponsored and other commercial insurance plans in
the United States. Using this database, we identified patients
18 to 64 years of age, who underwent bariatric surgery (GB,
SG, SLRY, LLRY, and BPDDS) between 2007 and 2014.
Exclusion criteria included patients without at least 1 year
of health insurance enrollment before their index bariatric
surgery, to adequately identify underlying comorbidities; patients without at least 1 year of follow-up insurance enrollment
after their index bariatric surgery, to ensure adequate followup; and patients with any kidney stone diagnosis within 1 year
before or within 30 days after bariatric surgery, suggestive of
preexisting stone disease (Fig. 1).
Bariatric and stone procedures were identified using Current
Procedural Terminology, Fourth Edition (CPT) codes (Supplementary Table S1). All procedures required supporting information to confirm that the procedure was performed.
Information used to confirm surgical procedures included
procedure claims from both a provider and facility (either CPT4 or International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) procedure codes for inpatient surgeries), or a procedure claim for surgery plus either a
provider anesthesia claim or facility revenue codes for operating room or anesthesia services. Distinction was not made between bariatric procedures performed laparoscopically versus
open as this likely does not affect stone outcomes. CPT coding
defines LLRY as a nonabsorptive alimentary limb greater than
150 cm and SLRY as a limb less than 150 cm. Stone procedures
included shockwave lithotripsy, ureteroscopy, percutaneous
nephrolithotomy, and open stone procedures.
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ICD-9-CM diagnosis codes were used to identify comorbidities, as defined by Elixhauser.6,7 New stone diagnoses were identified with a coding definition previously
validated by Semins et al.8 See Supplementary Table S1 for a
full list of the variable coding definitions. Comorbidities were
captured within the year preceding and during the bariatric
surgery admission, and required either two outpatient claims
coded at least 30 days apart or one inpatient claim, as we have
described previously.9
Statistical analyses

Descriptive statistics were performed using chi-square,
Student’s t-test, and Mann-Whitney U tests, as appropriate.
We performed two analyses using Cox proportional hazards
models. In the first, we used time to first coding of stone
diagnosis as the event of interest, and in the second, we used
time to first stone procedure as the event of interest. By
performing these analyses in parallel, with separately coded
events, we sought to overcome some of the possible limitations of miscoding in our administrative dataset. In both analyses, patients were censored at the first of a second bariatric
procedure, loss of health insurance enrollment, and inpatient
death. Kaplan-Meier curves were started at 30 days after
bariatric surgery since a stone event within 30 days of bariatric surgery was an exclusion criterion.
Univariable and multivariable Cox models were used to
examine the hazards associated with the different bariatric
surgeries and other known associated risk factors including age, diabetes mellitus,10 male sex,11 hypertension,12 and
geographical region.13 GB was used as the reference bariatric
surgery for analysis as available literature suggests it is not
associated with increased stone formation.4 Although certain
variables, like paralysis, are known risk factors for stone
formation, they were not included in our final model because
the numbers of these patients were very small in this cohort.
Age was grouped in discrete 10-year increments.
On graphical assessment of the proportional hazard’s assumption, the Kaplan-Meier plots demonstrated changing
slopes of the survival curves for stone diagnosis and stone
procedure with respect to the referent GB. For this reason, an
extended Cox model was implemented, partitioning the time
axis into two time intervals using a Heaviside function.14 For
diagnoses, a time interval was implemented at 36 months
where the slopes of the GB and SG curves where observed
to converge (Fig. 2A). For procedures, a time interval was
implemented at 18 months where slopes began to diverge
(Fig. 2B). Graphical assessment of the proportional hazards’
assumption for other covariates with Kaplan-Meier plots was
otherwise unremarkable.
Post hoc comparisons were performed on the multivariable Cox models using a Bonferroni correction for multiple
comparisons with the adjusted a set at 0.00625.
Results

We identified 281,776 patients from 18 to 64 years of age
coded for bariatric surgery between 2006 and 2015. Around
116,304 met all inclusion criteria and were included for final
analysis with a median follow-up of 31.6 months (minimum
12.0 months and maximum 108 months) (Fig. 1).
Demographics and clinical characteristics of the bariatric
surgery groups are shown in Table 1. The largest number of
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FIG. 1.

Cohort selection flow chart.

patients in our cohort underwent SLRY (n = 45,413), followed by GB (n = 38,615) and SG (n = 30,153). A smaller
number of patients underwent LLRY (n = 1,496) and BPDDS
(n = 627). Female sex predominated in all groups and geographic variation was observed in type of bariatric surgery
patients received (both p < 0.001), with highest utilization of
GB in the South and SG in the Northeast.
Kaplan-Meier plots for time to stone diagnosis and time
to stone procedure after the four types of bariatric procedures are shown in Figure 2A and B. The highest incidence
of new stone diagnosis and stone procedures was observed
for BPDDS, followed by LLRY and SLRY, and then SG
and GB.
The comparative incidence of new stone diagnosis and
stone procedure per person-year of observation for all patients, and separately for male and female patients are shown
in Table 2. For patients undergoing malabsorptive surgery, a
nearly twofold increase in new stone diagnosis and stone
procedures was observed for males compared to females.

The results from the multivariable extended Cox proportional hazards models are shown in Table 3 (univariable
results are shown in Supplementary Table S2). The independent risk of new stone diagnosis from 1 to 36 months,
compared to GB, was 4.54 for BPDDS (95% confidence interval [CI] 3.66–5.62), 2.12 for LLRY (95% CI 1.74–2.58),
2.15 for SLRY (95% CI 2.02–2.29), and 1.35 for SG (95%
CI 1.25–1.46). From 36 to 60 months, the risk of new stone
diagnosis was 4.65 for BPDDS (95% CI 2.85–7.57), 1.56 for
LLRY (95% CI 0.99–2.46), 1.29 for SLRY (95% CI 1.12–
1.50), and 0.77 for SG (95% CI 0.57–1.03).
The independent risk of stone procedure from 1 to 18
months, compared to GB, was 5.61 for BPDDS (95% CI
3.11–10.13), 3.23 for LLRY (95% CI 1.99–5.24), 3.23 for
SLRY (95% CI 2.66–3.91), and 1.71 for SG (95% CI 1.36–
2.14). From 18 to 60 months, the risk of new stone procedures
was 7.50 for BPDDS (95% CI 4.73–11.89), 2.35 for LLRY
(95% CI 1.49–3.70), 2.11 for SLRY (95% CI 1.78–2.50), and
0.98 for SG (95% CI 0.75–1.29).
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FIG. 2. (A, B) Kaplan-Meier survival curves for time to stone diagnosis and stone procedure. Shading indicates 95%
confidence interval. Number at risk is listed at yearly increments.
Male sex was associated with 1.63-fold increased risk of
stone diagnosis (95% CI 1.55–1.72) and 1.53-fold increased
risk of stone procedure (95% CI 1.37–1.70). Supplementary
Figure 1A–D show Kaplan-Meier plots for time to new stone
diagnosis and time to stone procedure stratified by sex.

Post hoc analyses comparing the risk of stone diagnosis
and stone procedure are shown in Table 4. For stone diagnosis risk, no difference was observed between LLRY and
SLRY in either time period ( p ‡ 0.407). BPDDS was associated with significantly greater risk of stone diagnosis than
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Table 1. Demographic Characteristics and Underlying Comorbidities of Patients
Who Underwent Bariatric Surgery from 2007 to 2014
GB (n = 38,615) SG (n = 30,153) SLRY (n = 45,413) LLRY (n = 1,496) BPDDS (n = 627)
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Variable (%)
Age [SD]
Female sex
Region of the United States
North East
North Central
South
West
Unknown
Coronary artery disease
Chronic pulmonary disease
Diabetes mellitus
Fluid and electrolyte disorders
Hypertension
Hypothyroidism
Paralysis
Chronic renal failure
Rheumatoid arthritis
Depression

44.1 [10.4]
30,552 (79.1)
5870
7688
17,776
6798
483
1085
3214
8550
333
17,092
3248
26
211
617
2751

(15.2)
(19.9)
(46.0)
(17.6)
(1.3)
(2.8)
(8.3)
(22.1)
(0.9)
(44.3)
(8.4)
(0.1)
(0.5)
(1.6)
(7.1)

44.0 [10.3]
23,406 (77.6)
5361
5703
14,044
4797
248
804
2726
6886
343
140,141
2985
20
262
604
2713

(17.8)
(18.9)
(46.6)
(15.9)
(0.8)
(2.7)
(9.0)
(22.8)
(1.1)
(46.6)
(9.9)
(0.1)
(0.9)
(2.0)
(9.0)

44.8 [10.3]
35,387 (77.9)
7251
10,031
18,432
9042
657
1529
4183
14,844
519
21,925
4136
26
394
830
3612

(16.0)
(22.1)
(40.6)
(19.9)
(1.4)
(3.4)
(9.2)
(32.7)
(1.1)
(48.3)
(9.1)
(0.1)
(0.9)
(1.8)
(8.0)

44.7 [10.4]
1153 (77.1)
181
822
341
72
80
46
144
429
11
670
118
2
8
17
123

(12.1)
(54.9)
(22.8)
(4.8)
(5.3)
(3.1)
(9.6)
(28.7)
(0.7)
(44.8)
(7.9)
(0.1)
(0.5)
(1.1)
(8.2)

43.9 [10.2]
454 (72.4)
89
164
186
179
9
24
52
175
11
306
59
0
6
8
61

(14.2)
(26.2)
(29.7)
(28.5)
(1.4)
(3.8)
(8.3)
(27.9)
(1.8)
(48.8)
(9.4)
(0.0)
(1.0)
(1.3)
(9.7)

BPDDS = biliopancreatic diversion with duodenal switch; GB = gastric banding; LLRY = long-limb Roux-en-Y; SD = standard deviation;
SG = sleeve gastrectomy; SLRY = short-limb Roux-en-Y.

all other procedures ( p < 0.001), and SG was associated with
significantly less risk of stone diagnosis risk than SLRY
( p < 0.001).
Similar post hoc results were observed for stone procedure
risk where BPDDS was associated with significantly greater
risk than other procedures ( p < 0.001), except for 1–18 months
when very few stone procedures were performed, and no significant difference was observed between BPDDS and SLRY
( p = 0.058). As in stone diagnosis, SG was associated with less
stone procedure risk than SLRY ( p < 0.001) and no difference
was observed between SLRY and LLRY ( p ‡ 0.636).
Discussion

In this study, we demonstrate that kidney stone diagnosis
and kidney stone removal after bariatric surgery exist on a
spectrum, with higher risk of stone diagnosis and stone procedures in patients undergoing more malabsorptive procedures. BPDDS patients were at higher risk than LLRY and
SLRY patients, all of whom were at higher risk than patients
undergoing SG and GB.
Prior studies on kidney stone formation after bariatric
surgery support these results, but lack our study’s granularity.

Most studies have looked at one type of bariatric surgery and
do not compare between the different types of bariatric surgeries. Several studies have demonstrated increased stone
formation and oxaluria after Roux-en-Y gastric bypass compared to obese controls,3,15,16 whereas other studies have
demonstrated no difference in stone formation and oxaluria
among restrictive bariatric surgery patients (primarily GB)
compared to obese controls.4,5 Lieske et al. retrospectively
compared a number of ‘‘restrictive’’ patients and ‘‘malabsorptive’’ patients (undergoing BPDDS or very LLRY) to
patients receiving SLRY, but no statistically significant difference was observed as the study was underpowered for this
comparison.3 The focused investigations of these other studies
highlight the significance of our results where the common
bariatric surgeries were compared among themselves.
Our results mostly align with our hypothesis that SG and
GB would have the lowest risk of nephrolithiasis with increasing risk for SLRY, LLRY, and BPDDS, respectively.
However, two main results differed from this hypothesis.
First, we did not observe a significant difference between
LLRY and SLRY in risk of stone diagnosis or stone procedure, despite LLRY being a more malabsorptive surgery.
This may reflect the simplification of a continuous variable to

Table 2. Incidence of New Stone Diagnosis and Stone Procedure After Bariatric
Surgery in All Patients and Stratified by Sex
New stone diagnosis and procedure incidences per 100 person-years
All patients
Bariatric
procedure
GB (n = 38,615)
SG (n = 30,153)
SLRY (n = 45,413)
LLRY (n = 1496)
BPDDS (n = 627)

Female patients

Male patients

Stone
diagnosis

Stone
procedure

Stone
diagnosis

Stone
procedure

Stone
diagnosis

Stone
procedure

1.3
1.9
2.8
2.8
6.4

0.3
0.4
0.7
0.8
1.7

1.2
1.7
2.4
2.3
5.0

0.2
0.3
0.6
0.5
1.3

1.9
4.1
4.7
21.3
10.4

0.4
0.9
1.9
8.4
2.9

KIDNEY STONE RISK AFTER BARIATRIC SURGERY
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Table 3. Results of Multivariable Extended Cox Proportional Hazards Models Comparing Time
to Stone Diagnosis and Time to Stone Procedure After Bariatric Surgery
Time to stone diagnosis
Adjusted hazard
ratio (95% CI)
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Variable
Age <30 (referent)
30–40
40–50
50–60
>60
Males
GB (referent)
SG (1–36 months)
SLRY (1–36 months)
LLRY (1–36 months)
BPDDS (1–36 months)
SG (36–60 months)
SLRY (36–60 months)
LLRY (36–60 months)
BPDDS (36–60 months)
Comorbidities
Coronary artery disease
Diabetes mellitus
Depression
Hypertension
Region of the United States
North East (referent)
North Central
South
West
Unknown

p

1.35
2.15
2.12
4.54
0.77
1.29
1.56
4.65

1.00
(1.03–1.28)
(1.1–1.37)
(1.08–1.34)
(1.05–1.39)
(1.55–1.72)
1.00
(1.25–1.46)
(2.02–2.29)
(1.74–2.58)
(3.66–5.62)
(0.57–1.03)
(1.12–1.50)
(0.99–2.46)
(2.85–7.57)

<0.001
<0.001
<0.001
<0.001
0.080
<0.001
0.053
<0.001

1.17
1.07
1.22
1.04

(1.03–1.32)
(1.01–1.13)
(1.12–1.33)
(0.99–1.10)

0.014
0.014
<0.001
0.098

1.13
1.14
0.98
0.99

1.00
(1.04–1.23)
(1.06–1.22)
(0.90–1.07)
(0.78–1.24)

0.002
<0.001
0.718
0.906

1.15
1.23
1.21
1.21
1.63

0.009
<0.001
<0.001
0.008
<0.001

Time to stone procedure
Variable
Age <30 (referent)
30–40
40–50
50–60
>60
Males
GB (referent)
SG (1–18 months)
SLRY (1–18 months)
LLRY (1–18 months)
BPDDS (1–18 months)
SG (18–36 months)
SLRY (18–36 months)
LLRY (18–36 months)
BPDDS (18–36 months)
Comorbidities
Coronary artery disease
Diabetes mellitus
Depression
Hypertension
Region of the United States
North East (referent)
North Central
South
West
Unknown

Adjusted hazard
ratio (95% CI)

p

1.71
3.23
3.23
5.61
0.98
2.11
2.35
7.50

1.00
(1.19–2.06)
(1.55–2.65)
(1.62–2.78)
(1.73–3.26)
(1.37–1.70)
1.00
(1.36–2.14)
(2.66–3.91)
(1.99–5.24)
(3.11–10.13)
(0.75–1.29)
(1.78–2.5)
(1.49–3.7)
(4.73–11.89)

<0.001
<0.001
<0.001
<0.001
0.909
<0.001
<0.001
<0.001

1.16
1.12
1.25
0.92

(0.92–1.48)
(1–1.25)
(1.05–1.49)
(0.83–1.02)

0.215
0.045
0.013
0.124

1.61
1.35
0.93
1.13

1.00
(1.36–1.90)
(1.15–1.58)
(0.77–1.13)
(0.69–1.83)

<0.001
<0.001
0.483
0.629

1.57
2.03
2.13
2.37
1.53

0.001
<0.001
<0.001
<0.001
<0.001

CI = confidence interval.

a binary; CPT coding defines LLRY as a nonabsorptive alimentary limb greater than 150 cm and SLRY as less than
150 cm. One hundred fifty centimeter may not represent the
most discerning threshold to differentiate levels of malabsorption. To our knowledge, no investigation has evaluated
the relationship between limb length as a continuous variable
and oxalate levels or stone incidence.
Second, a significantly greater risk of stone diagnosis and
stone procedure was observed in SG compared to GB, despite
both being restrictive procedures thought not to increase

stone risk.5 This increased risk was observed in the time
period immediately after SG, with no significant difference in
diagnosis risk after 18 months and no significant difference in
procedure risk after 36 months. The underlying mechanisms
in restrictive procedures are not fully understood, and thus an
unknown physiologic difference between SG and GB may
partially explain this difference in stone risk. This finding is
supported by a study that found an increased incidence of
stone formation after SG compared to GB; however, this
study lacked any statistical comparison.17 Regardless, the

Table 4. Post Hoc Comparisons of the Risk of Stone Diagnosis and Stone Procedures
Between SG, SLRY, LLRY, and BPDDS
Stone diagnosis comparisons
Contrasts

a

BPDDS vs SLRY (1–36 months)
BPDDS vs SG (1–36 months)
LLRY vs SLRY (1–36 months)
SLRY vs SG (1–36 months)
BPDDS vs SLRY (36–60 months)
BPDDS vs SG (36–60 months)
LLRY vs SLRY (36–60 months)
SLRY vs SG (36–60 months)
a

Stone procedure comparisons
p

b

<0.001
<0.001
0.884
<0.001
<0.001
<0.001
0.407
<0.001

Comparisons with GB were made in the primary Cox analysis.
Bonferroni-corrected a set at 0.00625.

b

Contrastsa

pb

BPDDS vs SLRY (1–18 months)
BPDDS vs SG (1–18 months)
LLRY vs SLRY (1–18 months)
SLRY vs SG (1–18 months)
BPDDS vs SLRY (18–60 months)
BPDDS vs SG (18–60 months)
LLRY vs SLRY (18–60 months)
SLRY vs SG (18–60 months)

0.058
<0.001
0.99i4
<0.001
<0.001
<0.001
0.636
<0.001

Downloaded by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE St. Louis E-PACKAGE from www.liebertpub.com at 06/14/21. For personal use only.

680

comparative risk of stones for SG versus GB was much
smaller than for the other bariatric surgeries we examined and
likely less clinically significant.
Although BPDDS is not as common as the other bariatric
surgeries compared in this study, it remains relevant because of
its greater prominence in certain countries and its greater success in addressing obesity-related outcomes.18–20 In addition to
previously reported adverse events, our results suggest that
BPDDS patients are also at greatly increased risk for stones.20
Reflecting reported trends in patients undergoing bariatric surgery, our study from 2007 to 2014 had a much
higher number of female patients than males.21 Male patients
undergoing bariatric surgery had a higher risk of stone diagnosis and procedures, especially after malabsorptive surgery,
suggesting this group is uniquely at risk. Males are known
to be at higher risk of stone formation,11 an association that
persists and is seemingly accentuated after bariatric surgery
in our study. Possibly, the predilection of male patients to
form oxalate stones may be exacerbated by the oxaluria inherent to malabsorptive bariatric surgery.22
The mean age for patients undergoing each bariatric surgery in our cohort was *44 years. The median follow-up of
31.6 months reflects only a small proportion of a patient’s
remaining life expectancy.23 Long-term adverse sequelae in
bariatric surgeries are of special relevance owing to the
middle age of these patients, who may be potentially burdened by complications for decades to come.
This study has several limitations. First, obesity alone is
associated with kidney stone formation.24 Although all subjects in this study can be assumed to be obese, there are likely
variations in the degree of obesity between patients receiving
different procedures. Given the inability to calculate body
mass index using administrative data, we chose not to attempt
to control for this potential confounder.25 Nevertheless, the
risks of stone formation associated with increasing obesity
reported in the literature are small in comparison to the risks
we observed in stone diagnosis and stone procedure among
different surgeries.24 In addition, we controlled for obesityrelated comorbidities, including diabetes mellitus, hypertension, and coronary artery disease, to minimize residual
confounding.
Second, baseline characteristics differed between cohorts
receiving different bariatric surgeries. Patients receiving more
malabsorptive surgeries tended to have more obesity-related
comorbidities such as diabetes mellitus, hypertension, and
coronary artery disease. These were controlled for in multivariable analysis when these comorbidities had a literaturesupported relationship to stone formation.
Finally, this administrative cohort is limited by its retrospective nature and the inaccuracies of coding. Given that
kidney stones are a long-term complication of bariatric surgery, recent prospective trials on bariatric surgery are
unlikely to be sufficiently powered or have long enough followup to adequately observe this outcome. Furthermore, by using
stone diagnosis and stone procedures in parallel analyses, we
attempted to overcome miscoding of stone diagnosis.
Conclusions

BPDDS is associated with greater stone risk compared to
all other bariatric surgeries, whereas LLRY and SLRY are
associated with a greater risk than the restrictive procedures,
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GB and SG. This work suggests that with greater malabsorption comes greater stone risk. We further observe that
male patients may be at unique risk for kidney stones after
bariatric surgery.
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Abbreviations Used
BPDDS ¼ biliopancreatic diversion with duodenal
switch
CI ¼ confidence interval
CPT ¼ Current Procedural Terminology
GB ¼ gastric banding
ICD-9-CM ¼ International Classification of Diseases,
Ninth Revision, Clinical Modification
LLRY ¼ long-limb Roux-en-Y
SD ¼ standard deviation
SG ¼ sleeve gastrectomy
SLRY ¼ short-limb Roux-en-Y

